Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence

@article{Jensen2015MedicalMA,
  title={Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence},
  author={Bjorn Jensen and J. Chen and Tim Furnish and M. Wallace},
  journal={Current Pain and Headache Reports},
  year={2015},
  volume={19},
  pages={1-9}
}
  • Bjorn Jensen, J. Chen, +1 author M. Wallace
  • Published 2015
  • Medicine
  • Current Pain and Headache Reports
  • Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems. The route of delivery of cannabis is important as the bioavailability and metabolism are very different for smoking versus oral/sublingual routes. Gold standard clinical trials are limited; however, some… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    As medical cannabis use becomes more common in the United States, it is essential to understand the ways in which adults who use medical cannabis perceive the benefits of cannabis… Expand
    ConditionsCannabis Use, Insomnia Chronic
    InterventionBehavioral
    NEWS ARTICLE
    Tetrahydrocannabinol – friend or foe? – Debate

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 102 REFERENCES